Statistically significant improved survival was found in Kaplan–Meier analysis for patients in the RIM group with 83.46 (8.4–193.1) months in RIM and 24.8 (0.5–298.9) months in the maintenance group (log rank = 0.02) and showed a trend in multivariate cox regression ( p = 0.054, HR = 14.3, CI = 0.96–213.67).
Treatment with buprenorphine as compared with methadone was not associated with psychological symptom score in men ( B = −0.89, 95% CI −2.08 to 0.30, P = 0.141), but showed a trend towards statistical significance in women ( B = −1.45, 95% CI −2.93 to 0.03, P = 0.054; Table 3 ).
The interaction of lesion group x surgery for the subjective values (V1 RL ) showed a trend for significance (p=0.054) ( Figure 3—figure supplement 1 ).
Although LGR5 + cell populations were expanded, there was no change in WNT target gene expression, including cyclin D1 , C-MYC , DKK1 , or β-CATENIN , and AXIN2 expression showed a trend to be decreased in SBS compared with normal biopsies ( Figure 4A, P = 0.054).
At follow up, patients treated with curcumin showed a trend towards lower subcutaneous fat area at L3, total adipose area at L3 and total estimated body fat as compared to the patients in the control group (Table 2 , p=0.054, 0.07, and 0.07, respectively).
Here, MCH levels in CSFs from orexin-deficient narcolepsy children showed a trend towards higher levels (p = 0.054) than in CSFs from orexin-normal children, although raised levels were not previously found in 14 patients with narcolepsy [ 25 ].
RA showed a trend towards statistical significance with higher values in the post-fatigue condition (149.4 ± 58.6 vs. 1319.5 ± 526.5 mm 2 ; p = 0.054; η p 2 = 0.322).
For HARMS2-AF, only estimated weekly standard drinks was not significant between probable AF (n = 550) and no AF (n = 10,244), although it showed a trend ( P = 0.054).
This analysis indicated that the microbicide alone over the entire course of parts 1 and 2 showed a trend toward protection (OR, 0.26 [0.06:1.02]; P = 0.054; Table 6 ), whereas the microbicide and vaccine combined provided significant protection, with a 91% reduction in the per-exposure probability of infection ( P = 0.004; Table 6 ).
PRP/SPM-high treatment also significantly reduced the gene expression of MMP13 ( p = 0.034) and showed a trend toward lower COL2A1 expression ( p = 0.054) compared to PRP/SPM-low.
For BrdU and NeuN double labeling, Ngf cKO mice also showed a trend for lower level of BrdU+/NeuN+ cell number ( p = 0.054, t (14) = 2.09) (Fig. 1C ).
PFS showed a trend in favor of Arm A (log-rank p=0.054).
Entering hippocampal MTR and hippocampal DIR lesions as predictors revealed that only hippocampal [Glu] showed a trend for predicting PAL trials at first attempt (coeff.=0.60, 95% CI −0.01 to 1.13, p=0.054, PCC=0.59).
Although dyslipidemia showed a trend towards an adverse effect on exercise capacity, it did not reach statistical significance ( p = 0.054).
In open-field test, RMANOVA with the intrasubject factor of time (1–20 min, df = 19) and the intersubject factor of genotype showed a trend-level effect of genotype ( F = 4.0, P = 0.054) for locomotor activity.
Hyponatremic CRS patients showed a trend for a higher in-hospital mortality (15.6% versus 7.6%, p = 0.054), but no difference in the one-year mortality (43.3% versus 40.1%, p = 0.692).
Median TTP showed a trend of prolongation in DCF regimen without reaching statistically significant difference (p = 0.054) ( Figure 5 ).
In quartile analysis, compared with the first quartile, the fourth quartile showed a trend toward increased DR risk (OR: 1.60, 95% CI: 0.99–2.59, P = 0.054), with a significant dose-response trend (P for trend = 0.040).
Controls displayed a decrease in alpha power between −400 and −100 ms before predTs compared to randTs (e.g., FCz: p = 0.002); whereas adults with ASD showed a trend for a pre-stimulus alpha increase before predTs compared to randTs (e.g., FCz: p = 0.054).
The pre-administration baseline AαVal541 level of the AATD patients before they received their first AAT augmentation therapy showed no correlation with baseline pulmonary function, although diffusion capacity (KCO) showed a trend to a negative correlation with baseline AαVal541 level (Spearman’s correlation coefficient—0.624, p = 0.054). 2.4.
The ratio of Aβ 40 :Aβ 38 showed a trend toward decreased Aβ 40 , which bordered on significance in CSF ( P = .054) and CM ( P = .028) ( Table 1 ). 3.3.
5 A), whereas patients with preexisting ILA according to AI evaluation showed a trend toward poor PFS ( P = 0.054, Fig. 5 B).
Similarly, WHO grade (OR = 0.809, 95% CI 0.184–3.564, p = 0.779) and MIB-1 labeling index demonstrated no statistically significant association, although MIB-1 showed a trend toward lower odds (OR = 0.298, 95% CI 0.087–1.019, p = 0.054).
Patients with mMRC grade 1 showed a trend towards a higher risk of exacerbation in GOLD A groups (p=0.054) and a significantly increased risk of exacerbation in GOLD B (p<0.0001) compared with patients with mMRC grade 0. 58 In GOLD A/B groups with a high prevalence of mMRC grade 1, patients had significantly lower pulmonary function (p<0.0
AD patients had more bad time points removed than HC (2-sample t-test, two tailed, t(57) = 3.37, p < 0.001) and EMCI (2-sample t-test, two tailed, t(44) = 2.54, p < 0.02) and showed a trend difference compared to LMCI (2-sample t-test, two tailed, t(44) = 1.98, p = 0.054).